Another drug manufacturer settles with Oregon, dozens of states over price-fixing allegations

Glenmark, a generic drug manufacturer, has settled with Oregon and numerous other states for nearly $30 million, marking the fifth company to do so amid accusations of violating federal antitrust laws through price-fixing. Oregon Attorney General Dan Rayfield emphasized the importance of holding pharmaceutical companies accountable for such practices. This settlement is significant as it underscores the ongoing efforts to combat price-fixing in the pharmaceutical industry, which can lead to inflated drug prices and reduced access to necessary medications for consumers.